Stay updated on ALD403 in Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.

Latest updates to the ALD403 in Chronic Migraine Clinical Trial page
- Check3 days agoChange DetectedAdded a comprehensive Locations section listing study sites across US states and international locations (including New South Wales, Victoria, and Western Australia) and removed the previous per-state location headers in favor of a consolidated locations block; Revision: v3.3.3.SummaryDifference2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedNew note explains that publications are auto-filled from PubMed and may not be about the study, and the revision tag has been updated to v3.3.2. The prior PubMed note and older v3.2.0 revision text were removed.SummaryDifference0.1%

- Check38 days agoChange DetectedNotice about government funding status and NIH operating updates was removed from the page, removing guidance about data currency and where to check status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe new page adds a cookies consent banner and a redesigned header/footer, while the actual study details such as title, conditions, and outcomes are unchanged.SummaryDifference0.2%

- Check81 days agoChange DetectedNew operating-status notice and v3.2.0 release; removal of v3.1.0 indicates version update.SummaryDifference3%

- Check89 days agoChange DetectedAdds a new revision label (v3.1.0) and removes multiple drug-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a content scope reduction and version upgrade.SummaryDifference0.3%

Stay in the know with updates to ALD403 in Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.